Reuters logo
BRIEF-Dr.Reddy's Labs gets form 483 with 3 observations from USFDA for audit of Miryalaguda plant
February 21, 2017 / 1:10 PM / 7 months ago

BRIEF-Dr.Reddy's Labs gets form 483 with 3 observations from USFDA for audit of Miryalaguda plant

Feb 21 (Reuters) - Dr.Reddy’s Laboratories Ltd

* Says the audit of API manufacturing plant at Miryalaguda, by the US FDA, has been completed on February 21, 2017

* Co has been issued a form 483 with three observations Source text : [Dr. Reddy’s Laboratories Limited has informed the Exchange “The audit of API manufacturing plant at Miryalaguda, by the US FDA, has been completed on February 21, 2017. We have been issued a Form 483 with three observations, which we are addressing”] Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below